Elanco Animal Health Inc (ELAN)
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 24.07 | 26.26 | 23.97 | 25.74 | 11,506,066 |
| Nov 5, 2026 | 25.24 | 25.24 | 23.43 | 23.68 | 6,712,169 |
| Nov 4, 2026 | 25.18 | 25.45 | 24.62 | 25.31 | 7,746,225 |
| Nov 3, 2026 | 24.23 | 24.82 | 24.07 | 24.57 | 6,460,441 |
| Nov 2, 2026 | 23.55 | 24.23 | 23.31 | 24.10 | 6,539,890 |
| Oct 30, 2026 | 23.48 | 23.48 | 22.93 | 23.06 | 3,453,607 |
| Oct 29, 2026 | 22.84 | 23.25 | 22.77 | 23.24 | 3,488,765 |
| Oct 28, 2026 | 22.75 | 22.92 | 22.56 | 22.65 | 4,394,101 |
| Oct 27, 2026 | 22.91 | 23.19 | 22.59 | 22.65 | 4,985,660 |
| Oct 26, 2026 | 22.62 | 23.09 | 22.18 | 22.96 | 4,205,515 |
| Oct 23, 2026 | 22.44 | 22.76 | 22.31 | 22.52 | 4,277,981 |
| Oct 22, 2026 | 22.43 | 22.84 | 22.35 | 22.69 | 4,452,452 |
| Oct 21, 2026 | 22.98 | 22.98 | 22.23 | 22.55 | 4,860,730 |
| Oct 20, 2026 | 23.29 | 23.47 | 22.03 | 22.70 | 8,247,153 |
| Oct 19, 2026 | 23.71 | 23.96 | 23.45 | 23.49 | 2,900,356 |
| Oct 16, 2026 | 23.87 | 24.11 | 23.41 | 23.55 | 5,166,172 |
| Oct 15, 2026 | 22.83 | 23.79 | 22.80 | 23.54 | 6,652,168 |
| Oct 14, 2026 | 22.38 | 22.92 | 22.26 | 22.55 | 4,942,920 |
| Oct 13, 2026 | 22.63 | 22.77 | 22.22 | 22.41 | 3,345,254 |
| Oct 12, 2026 | 22.88 | 22.93 | 22.55 | 22.56 | 4,652,949 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SEE REMARKS | Grant/Award | 64.047 | $1.5K | Oct 30, 2026 | |
| EVP and CFO | Grant/Award | 8.544 | $197.02 | Oct 30, 2026 | |
| PRESIDENT, CEO AND DIRECTOR | Grant/Award | 122.59 | $2.8K | Oct 30, 2026 | |
| EVP and CFO | Grant/Award | 8.366 | $197.019 | Oct 16, 2026 | |
| PRESIDENT, CEO AND DIRECTOR | Grant/Award | 120.04 | $2.8K | Oct 16, 2026 | |
| SEE REMARKS | Grant/Award | 62.715 | $1.5K | Oct 16, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Dodge & Cox · also on 13F· may incl. warrants· filed May 2026 | 68.9M | 13.8% | 13G |
DODGE & COX | 67.4M | 13.5% | 13F |
FMR LLC · net of 13F· joint filing· may incl. warrants· filed Nov 2026 | 66.2M | 13.3% | 13G |
FMR LLC | 56.9M | 11.4% | 13F |
BlackRock, Inc. | 48.8M | 9.8% | 13F |
PRIMECAP MANAGEMENT CO/CA/ · also on 13F· may incl. warrants· filed May 2026 | 45.8M | 9.2% | 13G |
PRIMECAP MANAGEMENT CO/CA/ | 45.4M | 9.1% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Oct 2025 | 44.0M | 8.8% | 13G |
T. Rowe Price Investment Management, Inc. | 28.8M | 5.8% | 13F |
DIMENSIONAL FUND ADVISORS LP | 25.1M | 5.0% | 13F |
Insiders
- Modi Rajeev A.SEE REMARKS
- VanHimbergen Robert MEVP and CFO
- Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR
- Bettington Timothy JSEE REMARKS
- Anand Kapila KDirector
- Kurzius Lawrence ErikDirector
- O'Neill ShivGC AND CORP SEC
- Harrington Michael JDirector
- Herendeen PaulDirector
- Kinard David SSEE REMARKS
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate.
Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro.
Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
13F filers report 564.19M shares, more than the 499.83M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.
30d Avg
5.45M
60d Avg
5.52M
90d Avg
5.40M